From: Optimization of [18F]PSMA-1007 PET-CT using regularized reconstruction in patients with prostate cancer
Observer #1
Observer #2
AT 4,β1000
23 (74%)
30 (97%)
AT 4,β1100
28 (90%)
AT 6,β800
1 (3%)
4 (13%)
AT 6,β900
3 (10%)
AT 6,β1000
7 (23%)
2 (6%)
AT 8,β700
0
AT 8,β800
AT 8,β900
AT 16,β500